Advanced search

THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF TELCAGEPANT, A NOVEL CALCITONIN GENE RELATED PEPTIDE (CGRP) RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS AND MIGRAINEURS

(2009) CLINICAL PHARMACOLOGY & THERAPEUTICS. 85(Suppl. 1). p.S39-S40
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Han, T H, R L Blanchard, J Palcza, I De Lepeleire, T Laethem, A Martucci, K Willson, et al. 2009. “The Pharmacokinetics, Safety, and Tolerability of Telcagepant, A Novel Calcitonin Gene Related Peptide (cgrp) Receptor Antagonist, in Healthy Subjects and Migraineurs.” In Clinical Pharmacology & Therapeutics, 85:S39–S40. 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA: NATURE PUBLISHING GROUP.
APA
Han, T H, Blanchard, R. L., Palcza, J., De Lepeleire, I., Laethem, T., Martucci, A., Willson, K., et al. (2009). THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF TELCAGEPANT, A NOVEL CALCITONIN GENE RELATED PEPTIDE (CGRP) RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS AND MIGRAINEURS. CLINICAL PHARMACOLOGY & THERAPEUTICS (Vol. 85, pp. S39–S40). Presented at the 110th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA: NATURE PUBLISHING GROUP.
Vancouver
1.
Han TH, Blanchard RL, Palcza J, De Lepeleire I, Laethem T, Martucci A, et al. THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF TELCAGEPANT, A NOVEL CALCITONIN GENE RELATED PEPTIDE (CGRP) RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS AND MIGRAINEURS. CLINICAL PHARMACOLOGY & THERAPEUTICS. 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA: NATURE PUBLISHING GROUP; 2009. p. S39–S40.
MLA
Han, T H, R L Blanchard, J Palcza, et al. “The Pharmacokinetics, Safety, and Tolerability of Telcagepant, A Novel Calcitonin Gene Related Peptide (cgrp) Receptor Antagonist, in Healthy Subjects and Migraineurs.” Clinical Pharmacology & Therapeutics. Vol. 85. 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA: NATURE PUBLISHING GROUP, 2009. S39–S40. Print.
@inproceedings{539716,
  author       = {Han, T H and Blanchard, R L and Palcza, J and De Lepeleire, I and Laethem, T and Martucci, A and Willson, K and Xu, Y and Boyle, J and Butterfield, K and Mahon, C and Ermlich, S and Liu, W and Matthews, C Z and Xiao, A J and De Hoon, J and Gutierrez, M and Van Bortel, Lucas and Bieberdorf, F A and Van Hecken, A and Depre, M and Sinclair, S and Panebianco, D and Murphy, G},
  booktitle    = {CLINICAL PHARMACOLOGY \& THERAPEUTICS},
  issn         = {0009-9236},
  language     = {eng},
  location     = {National Harbor, MD},
  number       = {Suppl. 1},
  pages        = {S39--S40},
  publisher    = {NATURE PUBLISHING GROUP},
  title        = {THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF TELCAGEPANT, A NOVEL CALCITONIN GENE RELATED PEPTIDE (CGRP) RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS AND MIGRAINEURS},
  volume       = {85},
  year         = {2009},
}

Web of Science
Times cited: